Background
==========

Patients with Ebstein\'s anomaly are at risk of tachyarrhythmia, congestive heart failure and sudden cardiac death. There are few data regarding the value of modern non-invasive diagnostic testing in prediction of outcomes. Therefore, we aimed to evaluate cardiovascular magnetic resonance (CMR) and compare it to known predictors in Ebstein\'s anomaly.

Methods
=======

Seventy-nine consecutive adult patients (aged 37±15 years) with unrepaired Ebstein\'s anomaly underwent CMR and were followed prospectively for a mean of 3.5±2.6years.The major adverse cardiovascular events were defined as sustained ventricular tachycardia(VT)/heart failure hospital admission/transplantation or death. Sub-group analysis of first-onset atrial tachyarrhythmia (AT) was performed.

Results
=======

Univariate predictors of the major adverse cardiovascular events (n=6 patients; 3 death, 3 VT) were New York Heart Association class \>2 (Hazard ration (HR 7.66\[95%CI 1.535-38.204\],p=0.013), left ventricular (LV) ejection fraction (HR) 0.43\[95%CI 0.245-0.742\],p=0.003/5%), LV stroke volume (HR 0.69\[95%CI 0.515-0.923\],p=0.013/5mL) and right ventricular (RV) ejection fraction (HR 0.49\[95%CI 0.276-0.856\],p=0.012/5%); all remained significant even when tested solely for mortality. In all but one patient VT/death was preceded by AT and AT was predictive of major adverse cardiovascular events (HR 11.16\[95%CI 1.299-95.813\],p=0.028), emphasizing its role as an early marker of long-term adverse events. Freedom from first-onset AT (n=17 patients, 21.5%) declined during the follow-up. Univariate predictors for first-onset AT included RV ejection fraction (HR 0.65\[95%CI 0.463-0.907\],p=0.011/5%)\], RV/LV end diastolic volume ratio (HR 1.65\[95%CI 1.207-2.258\],p=0.002) and apical tricuspid septal leaflet displacement indexed to LV length (HR 1.03\[95%CI 1.002-1.068\],p=0.040); when used together as a score, risk prediction was further enhanced (HR 4.84\[95%CI 1.615-14.522\],p=0.005).

Conclusions
===========

Ventricular functional impairment by CMR was highly predictive of mortality and VT in a large contemporary cohort of unrepaired adult patients with Ebstein\'s anomaly supporting the potential of CMR in risk stratification and clinical follow up. Furthermore, VT and death were preceded in almost all patients by presentation of AT suggesting that AT predicts long term adverse events early on in the disease progression. Onset of AT was best predicted by routinely measured CMR parameters feasible for clinical approach.
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